Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2007
10/11/2007US20070238179 Cell Division and Proliferation Preferred Regulatory Elements and Uses Thereof
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070238168 Double mutant alpha-7 nicotinic acetylcholine receptor
10/11/2007US20070238160 microorganism capable of making an isoprenoid by changing the carbon flux through geranyl pyrophosphate, farnesyl pyrophosphate, or geranylgeranyl pyrophosphate and synthesis of isopentenyl pyrophosphate from an isoprenoid pathway; production of farnesol and geranylgeraniol
10/11/2007US20070238159 Production of Isoprenoids
10/11/2007US20070238157 Production of Isoprenoids
10/11/2007US20070238154 Humanized antibodies that recognize beta-amyloid peptide
10/11/2007US20070238153 Processes for improved disulfide bond formation in recombinant systems
10/11/2007US20070238152 Genetically programmed expression of proteins containing the unnatural amino acid phenylselenocysteine
10/11/2007US20070238151 Novel compounds
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238149 nucleotide sequences that code for polypeptides having oxidoreductase enzyme activity useful for biosynthesis of astaxanthin
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238134 Cell cycle proteins associated with rad9, compositions and methods of use
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070238127 Determining the presence of chronic myelogenous leukemia (CML) stem cells; beta -catenin; antitumor agents, anticancer agents
10/11/2007US20070238123 Method for determining cell cycle position
10/11/2007US20070238107 Method of assessing DNA mutability
10/11/2007US20070237876 Oilseed plant that produces mature seeds producing arachidonic acid
10/11/2007US20070237794 Compounds and Methods for Diagnosis and Treatment of Leishmaniasis
10/11/2007US20070237793 Attenuated or mutated pasteurella for use as tool in developing bactericidal agents; immunotherapy; immunogens for vaccines
10/11/2007US20070237791 Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (cfaB and CfaE) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic E.coli
10/11/2007US20070237784 IdeS, an IgG-degrading enzyme of Streptococcus pyogenes
10/11/2007US20070237769 Single domain antibodies directed against tumour necrosis factor-alpha and uses therefor
10/11/2007US20070237764 Binding polypeptides with restricted diversity sequences
10/11/2007US20070237761 Chimeric Anti Cd44 Antibodies and Their Use for Treating Acute Myeloid Leukemia
10/11/2007US20070237754 Transient immortalization
10/11/2007US20070237753 Method for selectively transducing pathologic mammalian cells using a tumor suppressor gene
10/11/2007US20070237745 SISP-1 (Stress induced Secreted Protein 1); induces apoptosis by interaction with p53; treating abnormal apoptosis such as tumor
10/11/2007US20070237744 Targeted Gene Delivery to Non-Phagocytic Mammalian Cells Via Bacterially Derived Intact Minicells
10/11/2007DE19860313B4 Verfahren zur Erkennung und Charakterisierung von Wirkstoffen gegen Pflanzen-Pathogene Methods for the detection and characterization of drugs against plant pathogens
10/11/2007DE102006016023A1 Funktionale Expression von Triacylglycerol-Lipasen Functional expression of triacylglycerol lipases
10/11/2007DE10158523B4 Hemmung der Transkription eines Zielgens in einer Zelle oder in Geweben Inhibition of transcription of a target gene in a cell or in tissue
10/11/2007CA2649045A1 Pharmaceutical composition
10/11/2007CA2648618A1 Novel anti-cd98 antibody
10/11/2007CA2648132A1 Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
10/11/2007CA2647931A1 Increased phytosterol content through overexpression of an acyl-coa sterol acyltransferase
10/11/2007CA2647846A1 Method for control of blood kinetics of antibody
10/11/2007CA2647718A1 Maize genes for controlling plant growth and organ size and their use in improving crop plants
10/11/2007CA2647498A1 Method of in vitro polynucleotide sequences shuffling by recursive circular dna molecules fragmentation and ligation
10/11/2007CA2647451A1 Process for the production of carotenoid compositions
10/11/2007CA2647142A1 Vegf receptor fusion protein and use thereof
10/11/2007CA2645904A1 Pseudomonas aeruginosa outer membrane protein pa0427
10/11/2007CA2638978A1 Plants having enhanced yield-related traits and a method for making the same
10/11/2007CA2585047A1 Method for quick determination of cytokeratin 19 (ck19) and primers and probes therefore
10/10/2007EP1842921A1 Recombined adenovirus p53 preparation for treating tumor
10/10/2007EP1842920A1 Cells coexpressing vitamin K reductase and vitamin K dependent protein and use thereof to improve the productivity of said vitamin K dependent protein
10/10/2007EP1842919A1 DNA sequences having anti-repressor activity
10/10/2007EP1842918A1 Receptor nucleic acids and polypeptides
10/10/2007EP1842917A1 Sequences of an Ih ion channel and their application
10/10/2007EP1842916A1 siRNA specific for the urokinase-type plasminogen activator receptor
10/10/2007EP1842915A1 Method of in vitro polynucleotide sequences shuffling by recursive circular DNA molecules fragmentation and ligation
10/10/2007EP1842914A1 Method and apparatus for disrupting cells and purifying nucleic acid using a single chamber
10/10/2007EP1842913A1 Method and apparatus for purifying nucleic acid on hydrophilic surface of solid support using hydrogen bonding
10/10/2007EP1842912A1 Method of breeding cells having improved tolerance to short-chain fatty acids
10/10/2007EP1842911A1 Hla-binding peptides, dna fragments encoding the same and recombinant vectors
10/10/2007EP1842910A1 Method of enzymatically synthesizing 3'-phosphoadenosine-5'-phosphosulfate
10/10/2007EP1842909A1 Method for removing desired chromosome and tailor-made medical treatment utilizing the same
10/10/2007EP1842906A1 Glucose dehydrogenase
10/10/2007EP1842905A1 Method of inducing differentiation of embryo-stem cell into hepatocyte and hepatocyte induced by the method
10/10/2007EP1842859A2 Monoclonal antibody specific for beta A4 peptide
10/10/2007EP1842857A1 Mutant interferon proteins and use thereof
10/10/2007EP1842856A2 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
10/10/2007EP1842558A1 Composition for inhibiting expression of target gene
10/10/2007EP1842553A1 Combination of an anti-EDb fibronectin domain antibody/IL2 fusion protein and a further small molecule
10/10/2007EP1842552A1 Treatment for diabetes
10/10/2007EP1842549A2 Optimized minigenes and peptides encoded thereby
10/10/2007EP1842548A1 Anti-hiv drug, polypeptide constituting the same, gene encoding the polypeptide and method of producing the anti-hiv drug
10/10/2007EP1842226A2 Homogeneous analyte detection
10/10/2007EP1841878A1 Method for the generation of virus producing cell lines and cell lines
10/10/2007EP1841877A2 Transgenic evaluation of activated mutant alleles of sos2 reveals a critical requirement for its kinase activity and c-terminal regulatory domain for salt tolerance in arabidopsis thaliana
10/10/2007EP1841876A2 An inducible deoxyhypusine synthase promoter from maize
10/10/2007EP1841875A2 Controlled production and delivery of biologically active agents by gut bacteria
10/10/2007EP1841874A2 Leader sequences for directing secretion of polypeptides and methods for production thereof
10/10/2007EP1841873A2 L-arabinose isomerase exhibiting minimum dependence on metal ions for its activity and for thermostability, isolated and characterized nucleotide sequence thereof
10/10/2007EP1841872A2 Hemoglobin overexpression in fungal fermentations
10/10/2007EP1841871A1 Novel l-lysine-inducible promoter
10/10/2007EP1841869A1 Use of atbg1 gene for the generation of transgenic plants with increased resistance to various abiotic stress
10/10/2007EP1841868A2 Inhibitor nucleic acids
10/10/2007EP1841867A1 COMPLEX CONTAINING SiRNA, ShRNA OR ANTISENSE MOLECULE AND FUNCTIONAL ENTITY, FOR IMPROVED SPECIFICITY AND DELIVERY
10/10/2007EP1841866A2 Nucleic acids for apoptosis of cancer cells
10/10/2007EP1841865A2 Inducible sirna expression cassette and method of use
10/10/2007EP1841864A2 Charge neutralization of polyion complexes
10/10/2007EP1841861A1 Method for producing a compound of interest in a filamentous fungal cell
10/10/2007EP1841789A2 Hiv resistance genes
10/10/2007EP1841788A1 Novel snake toxin
10/10/2007EP1841784A1 Vacuole targeting peptide and nucleic acid
10/10/2007EP1841783A2 Second tc complex from xenorhabdus
10/10/2007EP1841464A2 Rnai modulation of the nogo-l or nogo-r gene and uses thereof
10/10/2007EP1841463A2 Methods and compositions for treating, inhibiting and reversing disorders of the intervertebral disc
10/10/2007EP1766026A4 Glucose isomerase mutants
10/10/2007EP1601450A4 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells
10/10/2007EP1578982A4 Nucleic acid amplification methods
10/10/2007EP1546408A4 A METHOD FOR GENERATION OF A RANDOM RNAi LIBRARY AND ITS APPLICATION IN CELL-BASED SCREENS
10/10/2007EP1421187B1 Systems for in vivo site-directed mutagenesis using oligonucleotides
10/10/2007EP1414994B1 Vaccinia virus for diagnosis and therapy of tumors
10/10/2007EP1412488B1 Method for producing arachidonic acid in transgenic organisms
10/10/2007EP1399576B8 Test system for determining gene toxicities
10/10/2007EP1385882B1 Peptides and related molecules that bind to tall-1